The US Life division of reinsurance giant Munich Re is partnering with the American Cancer Society on cancer-related research initiatives, as well as helping partially fund two ACS Research Scholar Grants.
ACS supports research and training grants in a range of cancer-related disciplines at 57 institutions across the US and since 1947 has invested more than $4.9 billion, including funding 49 researchers who went on to win the Nobel Prize.
With this four-year partnership, Munich Re becomes the first company in the reinsurance space to support ACS Research Scholar Grants.
Recipients are early-stage investigators with innovative ideas that are on the cutting edge of science.
“We are honored to embark upon this journey with a leading advocacy organization making valuable contributions to the field of cancer research,” said Marc-Andre Giguere, President and Chief Executive Officer, US Life and Health, Munich Re Life US.
“Cancer mortality is an important area of focus for us and being able to support and develop pioneering ideas to prevent cancer-related deaths, improve quantity and quality of lives and identify treatments that enhance medical outcomes aligns perfectly with our values and mission.”
William Phelps, PhD, Senior Vice President for Extramural Research at the American Cancer Society, added, “To change the future of cancer, we need to continue to invest in the most brilliant young investigators and most innovative cancer research.”
“We are pleased to have a partner in Munich Re whose continued support of the Society’s mission will help us make a meaningful difference in every community.”
